J Nat Med
Alkaline hydrolysis of 2
obtained. Vanillic acid (1.7 mg) (5b) was recovered from
the EtOAc fraction, which showed the same R value (0.61)
f
A solution of compound 2 (17.3 mg) in 50 % aqueous 1,4-
dioxane (0.5 ml) was treated with 10 % aqueous KOH
as that of an authentic sample on TLC (silica gel,
CHCl :MeOH:H O = 10:3:1).
2
3
00
26
(
0.5 ml) and stirred at 60 °C for 4 h. The reaction mixture
Isovitexin 7-O-b-D-glucopyranosyl-2 -O-a-L-rhamnopy-
?
was neutralized with Dowex HCR W2 (H form), and then
the resin was removed by filtration. The filtrate was
extracted with EtOAc, and the EtOAc layer was evaporated
ranoside (5a): pale yellow powder, [a]D -38.3 (c = 0.60,
1
MeOH); H-NMR (600 MHz, CD OD): d 6.71, 6.73 (1H, s,
3
H-3), 6.98, 7.02 (1H, s, H-8), 7.92, 7.94 (2H, d, J = 8.8 Hz,
0
0
0
0
under vacuum to give 16a-hydroxygypsogenic acid (2a,
H-2 , 6 ), 6.95, 6.98 (2H, d, J = 8.8 Hz, H-3 , 5 ), 4.99, 5.04
1
.6 mg): 2a: amorphous powder; H-NMR (600 MHz,
00
7
(1H, d, J = 9.4 Hz, 9.3 Hz, respectively, H-1 ), 5.12, 5.26
0
00
0000
pyridine-d ): d 5.65 (1H, br s, H-12), d 5.19 (1H, br s,
(1H, br s, H-1 ), 5.13, 5.14 (1H, d, J = 8.4 Hz, H-1 ) (the
5
H-16), 4.70 (1H, dd, J = 12.0, 5.0 Hz, H-3), 3.50 (1H, br
former figures are from minor peaks and the latter from major
1
peaks; sugar signals were omitted from assignment); C-
3
d, J = 10.0 Hz, H-18), 2.80 (1H, t, J = 13.5 Hz, H-19a),
2
.47 (1H, dd, J = 11.9, 4.4 Hz, H-21a), 2.41 (1H, brd,
J = 14.3 Hz, H-22a), 2.34 (1H, br d, J = 14.5 Hz, H-15a),
.25 (1H, dd, J = 14.3, 4.7 Hz, H-22b), 2.06 (1H, d,
NMR (150 MHz, CD OD): d 167.0, 167.1 (C-2), 104.6, 104.4
(C-3), 184.5, 184.8 (C-4), 161.5, 162.3 (C-5), 112.0, 112.8 (C-
3
2
6), 164.5 (C-7), 95.8, 96.4 (C-8), 159.2, 158.8 (C-9), 107.2,
0 0 0
107.8 (C-10), 123.3, 123.2 (C-1 ), 129.9, 130.0 (C-2 , 6 ),
J = 11.2 Hz, H-5), 2.06–1.95 (2H, o, H -11), 2.00 (1H, br
2
0 0 0 00
d, J = 9.0 Hz, H-2a), 1.97 (1H, m, H-9), 1.78 (3H, s, H3-
117.3, 117.4 (C-3 , 5 ), 163.3, 163.4 (C-4 ), 73.4, 73.6 (C-1 ),
00 00 00
78.7, 78.3 (C-2 ), 81.5, 81.7 (C-3 ), 71.4, 71.3 (C-4 ), 82.4,
2
7), 1.75 (1H, br d, J = 12.8 Hz, H-7a), 1.70 (1H, dd,
00 00 000
J = 10.1, 1.3 Hz, H-6a), 1.67 (1H, br d, J = 13.5 Hz,
82.5 (C-5 ), 62.9, 62.4 (C-6 ), 102.9, 102.6 (C-1 ), 72.6, 72.5
000 000 000
(C-2 ), 71.6, 71.7 (C-3 ), 73.9, 74.1 (C-4 ), 70.4, 70.2 (C-
H-15b), 1.63 (3H, s, H -24), 1.59 (1H, br d, J = 11.2 Hz,
3
000 000 0000
H-6b), 1.58 (1H, br d, J = 12.5 Hz, H-1a), 1.39 (1H, br d,
J = 11.2 Hz, H-7b), 1.34 (1H, dd, J = 13.5, 6.0 Hz,
H-19b), 1.26 (1H, dd, J = 11.9, 6.4 Hz, H-21b), 1.22 (1H,
br d, J = 12.0 Hz, H-2b), 1.19 (1H, br d, J = 10.0 Hz,
H-1b), 1.16 (3H, s, H -26), 1.05 (3H, s, H -25), 1.02 (3H, s,
5 ), 18.2, 18.3 (C-6 ), 103.0, 102.9 (C-1 ), 75.4, 75.2 (C-
0000
0
000
0000
0000
2 ),77.8, 77.3(C-3 ), 72.3, 72.1(C-4 ),79.2, 78.8(C-5 ),
0000
63.7, 63.8 (C-6 ) (the former figures are from minor peaks
and the latter from major peaks); HR-ESI-MS (negative-ion
-
mode) m/z: 739.2086 [M - H] (Calcd for C H O :
3
3
33 39 19
1
739.2091). Vanillic acid (5b): H-NMR (400 MHz, CD OD):
1
3
H -30), 1.00 (3H, s, H -29); C-NMR (150 MHz, pyr-
3
3
3
00000
idine-d ): d 180.4 (C-23), 179.7 (C-28), 144.9 (C-13),
d 7.58 (1H, d, J = 1.8 Hz, H-2 ), 7.57 (1H, dd, J = 8.8,
5
00000 00000
1.8 Hz, H-6 ), 6.69 (1H, d, J = 8.8 Hz, H-5 ), 3.91 (3H,
1
22.0 (C-12), 75.3 (C-3), 74.4 (C-16), 54.3 (C-4), 51.8 (C-
1
3
00000
5
), 48.6 (C-17), 47.3 (C-9), 47.0 (C-19), 41.2 (C-18), 41.9
s,–OCH3); C-NMR (100 MHz, CD OD): d 168.6 (C-7 ),
3
00000 00000 00000 00000
(
C-14), 40.1 (C-8), 38.9 (C-1), 36.7 (C-10), 35.97 (C-15),
151.3 (C-4 ), 147.3 (C-3 ), 123.9 (C-6 ), 121.7 (C-1 ),
0
0000
00000
3
2
5.94 (C-21), 33.1 (C-7), 33.0 (C-29), 32.6 (C-22), 30.8 (C-
0), 27.6 (C-2), 26.9 (C-27), 21.5 (C-6), 23.7 (C-11), 24.5
114.4 (C-2 ), 112.4 (C-5 ), 55.0 (–OCH ); HR-ESI-MS
3
-
(negative-ion mode) m/z: 167.0352 [M - H] (Calcd for
(
(
C-30) 12.0 (C-24), 15.9 (C-25), 17.2 (C-26); HR-ESI-MS
-
negative-ion mode) m/z: 501.3222 [M - H] (Calcd for
C H O : 167.0350).
8 7 4
C H O : 501.3220).
3
0
45
6
Cytotoxicity analysis
Alkaline hydrolysis of 5
Cytotoxic activity toward lung adenocarcinoma cells was
determined by colorimetric cell viability assaying using
3-(4,5-dimethylthiazol-2-yl)-2,5-diphenyltetrazolium bro-
mide (MTT). Lung adenocarcinoma cell line A549 was
purchased from the Japanese Collection of Research
Bioresources Cell Bank, Japan. A549 cells were cultured in
Dulbecco’s modified Eagle’s medium supplemented with
10 % heat-inactivated FCS and kanamycin (100 lg/ml)
and amphotericin B (5.6 lg/ml).
A solution of compound 5 (9.7 mg) in 50 % aqueous 1,4-
dioxane (0.5 ml) was treated with 10 % aqueous KOH
(
0.5 ml) and stirred at 60 °C for 10 h. The reaction mixture
?
was neutralized with Dowex HCR W2 (H form), and then
the resin was removed by filtration. The filtrate was
extracted with EtOAc. The remaining aqueous layer was
evaporated under vacuum, and then the residue was sub-
jected to silica gel CC: 0.5 g, CHCl :H O:MeOH [50:3:1
3
2
In a 96-well plate, 1-ll aliquots of sample solutions
3
(
10 ml) ? 7:3:1 (10 ml) ? 6:4:1 (10 ml) ? MeOH]. On
and the cancer cells (5 9 10 cells/well) in 100 ll
medium were added to each well, and then the plate was
evaporation of the 6:4:1 eluate, isovitexin 7-O-b-D-glu-
0
0
copyranosyl-2 -O-a-L-rhamnopyranoside (5a, 6.0 mg) was
incubated at 37 °C under a 5 % CO2 atmosphere for
1
23